Get the Stockscreener App
2.65
1.53%
0.04
After Hours:
2.65
Kiora Pharmaceuticals Inc stock is traded at $2.65, with a volume of 16,646.
It is up +1.53% in the last 24 hours and down -9.56% over the past month.
Kiora Pharmaceuticals Inc is a clinical-stage biotechnology company developing and commercializing products for the treatment of orphan retinal diseases. As part of its development, KIO-301 is being studied for the treatment of retinitis pigmentosa, choroideremia, and Stargardt disease. It is a molecular photoswitch that has the potential to restore vision in patients with inherited and/or age-related retinal degeneration. KIO-104 is being developed for the treatment of posterior non-infectious uveitis. It is a next-generation, non-steroidal, immuno-modulatory, and small-molecule inhibitor of dihydroorotate dehydrogenase.
See More
Previous Close:
$2.61
Open:
$2.61
24h Volume:
16,646
Relative Volume:
0.27
Market Cap:
$9.10M
Revenue:
-
Net Income/Loss:
$2.81M
P/E Ratio:
-0.1847
EPS:
-14.3497
Net Cash Flow:
$7.14M
1W Performance:
+0.76%
1M Performance:
-9.56%
6M Performance:
-18.21%
1Y Performance:
-22.29%
1-Day Range:
$2.58
$2.67
1-Week Range:
$2.58
$2.80
52-Week Range:
$2.25
$4.18
Kiora Pharmaceuticals Inc Stock (KPRX) Company Profile
Name
Kiora Pharmaceuticals Inc
Sector
Industry
Phone
858-224-9600
Address
169 SAXONY RD., ENCINITAS
Compare KPRX with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
KPRX
Kiora Pharmaceuticals Inc
|
2.65 | 8.96M | 0 | 2.81M | 7.14M | -14.35 |
|
VRTX
Vertex Pharmaceuticals Inc
|
391.36 | 100.82B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
461.24 | 60.45B | 2.46B | -319.09M | -52.09M | -2.47 |
|
REGN
Regeneron Pharmaceuticals Inc
|
575.06 | 60.69B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ARGX
Argen X Se Adr
|
752.32 | 46.32B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
327.20 | 36.58B | 3.81B | -644.79M | -669.77M | -6.24 |
Kiora Pharmaceuticals Inc Stock (KPRX) Latest News
Breakout Move: What’s the beta of Kiora Pharmaceuticals Inc. stockQuarterly Trade Review & AI Enhanced Trading Alerts - خودرو بانک
What to do if you’re stuck in Kiora Pharmaceuticals Inc.Trade Volume Summary & Low Drawdown Momentum Ideas - newser.com
Using flow based indicators on Kiora Pharmaceuticals Inc.2025 Dividend Review & Real-Time Market Trend Scan - newser.com
Is Kiora Pharmaceuticals Inc.’s growth already priced inJuly 2025 EndofMonth & Low Drawdown Investment Ideas - خودرو بانک
Quarterly Earnings: What is Kiora Pharmaceuticals Incs debt to equity ratioMarket Sentiment Report & Verified Momentum Stock Ideas - خودرو بانک
Rate Hike: Is Kiora Pharmaceuticals Inc a defensive stockPortfolio Value Summary & Advanced Technical Signal Analysis - خودرو بانک
Aug Wrap: Is Kiora Pharmaceuticals Inc.’s growth already priced inWeekly Stock Recap & Consistent Profit Trade Alerts - خودرو بانک
Is it too late to sell Kiora Pharmaceuticals Inc.July 2025 Short Interest & Low Risk Growth Stock Ideas - newser.com
Detecting price anomalies in Kiora Pharmaceuticals Inc. with AI2025 Key Highlights & High Accuracy Buy Signal Tips - newser.com
Does Kiora Pharmaceuticals Inc. fit your quant trading model2025 Market WrapUp & High Accuracy Swing Entry Alerts - newser.com
Should you wait for a breakout in Kiora Pharmaceuticals Inc.Market Risk Analysis & Scalable Portfolio Growth Methods - Newser
Using RSI to spot recovery in Kiora Pharmaceuticals Inc.2025 Historical Comparison & Real-Time Stock Entry Alerts - Newser
Order flow analysis tools used on Kiora Pharmaceuticals Inc.July 2025 Highlights & Free Low Drawdown Momentum Trade Ideas - Newser
Technical signs of recovery in Kiora Pharmaceuticals Inc.Quarterly Trade Summary & Weekly Chart Analysis and Trade Guides - Newser
Volatility clustering patterns for Kiora Pharmaceuticals Inc.Earnings Overview Report & Precise Trade Entry Recommendations - Newser
Can Kiora Pharmaceuticals Inc. recover in the next quarterJuly 2025 Trends & Stepwise Trade Signal Implementation - Newser
How to recover losses in Kiora Pharmaceuticals Inc. stockLong Setup & Fast Exit/Entry Strategy Plans - Newser
Kiora Pharmaceuticals Inc. stock outlook for YEARWeekly Loss Report & Verified Stock Trade Ideas - Newser
Using data models to predict Kiora Pharmaceuticals Inc. stock movementWeekly Trade Analysis & Capital Efficiency Focused Ideas - Newser
Using data tools to time your Kiora Pharmaceuticals Inc. exitQuarterly Growth Report & Consistent Profit Trading Strategies - Newser
analyzing drawdowns of kiora pharmaceuticals inc. with statistical toolsWeekly Stock Report & Step-by-Step Swing Trade Plans - Newser
Will Kiora Pharmaceuticals Inc. stock go up soonJuly 2025 Sector Moves & Free Safe Capital Growth Stock Tips - Newser
How to integrate Kiora Pharmaceuticals Inc. into portfolio analysis toolsMarket Activity Recap & Community Verified Watchlist Alerts - Newser
Is Kiora Pharmaceuticals Inc. trending in predictive chart models2025 Retail Activity & Fast Gain Swing Trade Alerts - Newser
Combining machine learning predictions for Kiora Pharmaceuticals Inc.July 2025 Reactions & Consistent Income Trade Recommendations - Newser
Is now a turning point for Kiora Pharmaceuticals Inc.Insider Selling & AI Forecasted Stock Moves - Newser
Developing predictive dashboards with Kiora Pharmaceuticals Inc. dataPortfolio Update Report & AI Enhanced Execution Alerts - Newser
Kiora Pharmaceuticals Inc. stock prediction for this weekJuly 2025 WrapUp & Accurate Trade Setup Notifications - Newser
Technical analysis overview for Kiora Pharmaceuticals Inc. stock2025 AllTime Highs & Low Drawdown Investment Strategies - Newser
How to use a screener to detect Kiora Pharmaceuticals Inc. breakoutsNew Guidance & Free Real-Time Volume Trigger Notifications - Newser
Kiora Pharmaceuticals Inc Stock (KPRX) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.77%
1.53%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):